The $185 Million Bet That Spirulina Can Make Biologic Drugs Cheap Enough to Swallow

Lumen survived a biofuel bust and a pigment-price collapse by turning stubborn green microbes into miniature drug factories. Now its oral biologics face the test that matters: whether an elegant manufacturing trick can survive large clinical trials and the economics of medicine.